Pasithea Therapeutics Corp.
KTTA
$0.58
$0.00-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.03% | -46.91% | 14.46% | 17.88% | 16.44% |
| Total Depreciation and Amortization | 1.39% | 2.16% | 2.90% | -0.08% | 0.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 513.45% | 472.04% | 22.12% | -39.47% | 75.11% |
| Change in Net Operating Assets | -401.19% | 79.04% | 147.50% | -201.11% | -127.31% |
| Cash from Operations | -33.85% | -9.25% | 20.33% | 16.30% | 11.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -34.51% | 32.11% |
| Issuance of Common Stock | 3,667.71% | 21,322,233.33% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.95% | -105.95% | -105.58% | -- | 107,654.76% |
| Cash from Financing | 935.49% | 1,306.03% | 55.76% | 403.93% | 249.99% |
| Foreign Exchange rate Adjustments | 2,568.42% | 852.00% | 268.73% | 240.43% | 9.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 777.26% | 613.77% | 49.75% | 95.98% | 62.76% |